New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Does eating processed meats cause colorectal cancer?

Does eating processed meats cause colorectal cancer?

by Maddie Massy-Westropp,University of New South WalesCredit: Pixabay/CC0 Public DomainThey're integral to summer, as ubiquitous as a zinced-up nose or a backyard cricket game. From December
Oncology January 04,2024
Does eating processed meats cause colorectal cancer?

Does eating processed meats cause colorectal cancer?

by Maddie Massy-Westropp,University of New South WalesCredit: Pixabay/CC0 Public DomainThey're integral to summer, as ubiquitous as a zinced-up nose or a backyard cricket game. From December
Oncology January 04,2024
Experimental brain cancer drug fast tracked in clinical trials

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc
Oncology January 04,2024
Experimental brain cancer drug fast tracked in clinical trials

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc
Oncology January 04,2024
Experimental ovarian cancer diagnostic could lead to new precision oncology approach

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (
Oncology January 04,2024
Experimental ovarian cancer diagnostic could lead to new precision oncology approach

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (
Oncology January 04,2024
Experimental cancer vaccine shows promise in animal studies

Experimental cancer vaccine shows promise in animal studies

byNIH/National Institute of Allergy and Infectious DiseasesGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.10.006An experimental therapeutic cancer vaccine induced tw
Oncology January 04,2024
Experimental cancer vaccine shows promise in animal studies

Experimental cancer vaccine shows promise in animal studies

byNIH/National Institute of Allergy and Infectious DiseasesGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.10.006An experimental therapeutic cancer vaccine induced tw
Oncology January 04,2024
Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

by Jay Furst,Mayo ClinicCredit: AI-generated imageMore than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma
Oncology January 04,2024
Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

by Jay Furst,Mayo ClinicCredit: AI-generated imageMore than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma
Oncology January 04,2024
Tracking radiation treatment in real time promises safer, more effective cancer therapy

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi
Oncology January 04,2024
Tracking radiation treatment in real time promises safer, more effective cancer therapy

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi
Oncology January 04,2024
Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo
Oncology January 04,2024
Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo
Oncology January 04,2024
Identifying cancer genes' multiple personalities

Identifying cancer genes' multiple personalities

byCold Spring Harbor LaboratoryAn up-close look at a mouse's liver; the cells with dark centers were turned cancerous using a new gene-editing strategy devised by Semir Beyaz's lab. Cred
Oncology January 04,2024
Identifying cancer genes' multiple personalities

Identifying cancer genes' multiple personalities

byCold Spring Harbor LaboratoryAn up-close look at a mouse's liver; the cells with dark centers were turned cancerous using a new gene-editing strategy devised by Semir Beyaz's lab. Cred
Oncology January 04,2024
Metabolite from pomegranates improves the function of immune cells in their fight against cancer

Metabolite from pomegranates improves the function of immune cells in their fight against cancer

byEcole Polytechnique Federale de LausanneGraphical abstract. Credit:Immunity(2022). DOI: 10.1016/j.immuni.2022.09.014Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Ger
Oncology January 04,2024
Metabolite from pomegranates improves the function of immune cells in their fight against cancer

Metabolite from pomegranates improves the function of immune cells in their fight against cancer

byEcole Polytechnique Federale de LausanneGraphical abstract. Credit:Immunity(2022). DOI: 10.1016/j.immuni.2022.09.014Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Ger
Oncology January 04,2024
Crossroads: The role of biomarkers in the management of lumps in the breast

Crossroads: The role of biomarkers in the management of lumps in the breast

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new research perspective was published inOncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in
Oncology January 04,2024
Crossroads: The role of biomarkers in the management of lumps in the breast

Crossroads: The role of biomarkers in the management of lumps in the breast

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new research perspective was published inOncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in
Oncology January 04,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com